Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACEVU
ACE Convergence Acquisition
$9.77
-0.1%
$9.77
$9.27
$10.80
N/AN/A2,197 shs800 shs
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
$10.36
-0.2%
$10.36
$8.14
$11.35
N/AN/A4,697 shs400 shs
ADRAU
Adara Acquisition
$0.02
$0.02
$0.02
$11.20
N/AN/A1,795 shsN/A
EBACU
European Biotech Acquisition
$11.30
$9.84
$9.75
$10.49
N/AN/A2,500 shs5,714 shs
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
$24.98
0.0%
$24.98
$24.50
$25.49
N/AN/A3,395 shs400 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACEVU
ACE Convergence Acquisition
0.00%0.00%0.00%0.00%0.00%
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
0.00%0.00%0.00%0.00%0.00%
ADRAU
Adara Acquisition
0.00%0.00%0.00%0.00%0.00%
EBACU
European Biotech Acquisition
0.00%0.00%0.00%0.00%0.00%
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/AN/AN/AN/A
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
EBACU
European Biotech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACEVU
ACE Convergence Acquisition
0.00
N/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
0.00
N/AN/AN/A
ADRAU
Adara Acquisition
0.00
N/AN/AN/A
EBACU
European Biotech Acquisition
0.00
N/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/AN/A
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/AN/A
EBACU
European Biotech Acquisition
N/AN/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACEVU
ACE Convergence Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/A0.00N/AN/AN/AN/AN/A
ADRAU
Adara Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
EBACU
European Biotech Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/A
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/A
EBACU
European Biotech Acquisition
N/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ACEVU
ACE Convergence Acquisition
3N/AN/ANot Optionable
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
3N/AN/ANot Optionable
ADRAU
Adara Acquisition
847N/AN/ANot Optionable
EBACU
European Biotech Acquisition
2N/AN/ANot Optionable
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
34N/AN/ANot Optionable

Recent News About These Companies

Sachem Capital Corp. 7.125% Notes due 2024 (SCCB)

Media Sentiment Over Time

ACE Convergence Acquisition OTCMKTS:ACEVU

$9.77 -0.01 (-0.10%)
As of 11/22/2022

ACE Convergence Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the IT infrastructure software and semiconductor sectors. ACE Convergence Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.

Ackrell SPAC Partners I stock logo

Ackrell SPAC Partners I OTCMKTS:ACKIU

$10.36 -0.02 (-0.19%)
As of 08/31/2022

Ackrell SPAC Partners I Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on alcoholic and non-alcoholic beverage and wellness sectors. Ackrell SPAC Partners I Co. was founded in 2018 and is Claymont, Delaware.

Adara Acquisition OTCMKTS:ADRAU

$0.02 0.00 (0.00%)
As of 03/17/2023

Adara Acquisition Corp. was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry, it currently intends to concentrate its search for a target business operating in the consumer products and related industries.

European Biotech Acquisition NASDAQ:EBACU

European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Sachem Capital Corp. 7.125% Not stock logo

Sachem Capital Corp. 7.125% Not OTCMKTS:SCCB

$24.98 -0.01 (-0.04%)
As of 06/28/2024

since 2010, sachem capital has been financing opportunistic real estate transactions in the new england area. sachem capital provides quick, short-term bridge capital for real estate investors, builders or developers who need immediate funding or to solve an immediate problem. our creative real estate financing solutions are developed exclusively for those seeking alternatives to conventional bank loans. the executive team has extensive experience in real estate acquisitions, investments, management and development. our hands-on managers have the expertise to quickly assess complex opportunities and non-conventional situations to deliver a closing product that is efficient and opportunistic to our borrowers, and profitable to our shareholders. sachem capital was listed on the nyse on february 10, 2017. the company was designed to address the constant volatility and instability in today's financial markets. we are exited to share with you this extraordinary opportunity to seize favorabl